News at a glance.
Galenica increases sales growth in the third quarter
Ad hoc announcement pursuant to Art. 53 LR, Thursday, 24 October 2024
Following solid sales growth of 2.6% in the first half of 2024, Galenica grew more strongly again in the third quarter and generated net sales of CHF 2,864.8 million to the end of September 2024. With growth of 4.1%, Galenica outperformed the growth of the overall pharmaceutical market (+2.9%, IQVIA, pharmaceutical market Switzerland, YTD September 2024).
News at a glance
Here you will find all ad hoc announcements, press releases and news about the Galenica network. Stay up to date and subscribe to our ad hoc announcements and press releases by e-mail.
Latest ad hoc announcements and press releases
All relevant news from the Galenica network in our ad hoc announcements and press releases.
Downloads for media
Images of various business activities from the Galenica network and the Galenica logo for journalistic use.
«We demonstrate how we create added value within the Galenica network; for our customers, employees, investors, partners and Switzerland’s healthcare system.»
Iris Müller, Head of Corporate Communications